Patent · US Active

Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

US11690918B2 · kind B2 · utility

0Cited by

83References

15Claims

0Family size

Assignees

MedImmune Limited · US
ADC THERAPEUTICS SA · CH

Inventors

Patricius Hendrikus Cornelis Van Berkel · Épalinges, CH
Philip Wilson Howard · London, GB

Key dates

Filing date	May 26, 2020
Grant date	Jul 4, 2023
Priority date	—
Expiry date	Jul 17, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides conjugates of an isolated humanized anti-CD22 antibody and PBD dimers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.